CA2719833A1 - Compositions comprenant des inhibiteurs d'arnox pour l'inhibition d'especes d'oxygene reactif - Google Patents

Compositions comprenant des inhibiteurs d'arnox pour l'inhibition d'especes d'oxygene reactif Download PDF

Info

Publication number
CA2719833A1
CA2719833A1 CA2719833A CA2719833A CA2719833A1 CA 2719833 A1 CA2719833 A1 CA 2719833A1 CA 2719833 A CA2719833 A CA 2719833A CA 2719833 A CA2719833 A CA 2719833A CA 2719833 A1 CA2719833 A1 CA 2719833A1
Authority
CA
Canada
Prior art keywords
arnox
extract
salicaceae
aging
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2719833A
Other languages
English (en)
Inventor
Dale Kern
Christiaan Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nu Skin International Inc
Nox Technologies Inc
Original Assignee
Nu Skin International Inc
Nox Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nu Skin International Inc, Nox Technologies Inc filed Critical Nu Skin International Inc
Publication of CA2719833A1 publication Critical patent/CA2719833A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2719833A 2008-03-28 2008-03-28 Compositions comprenant des inhibiteurs d'arnox pour l'inhibition d'especes d'oxygene reactif Abandoned CA2719833A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058683 WO2009120214A1 (fr) 2008-03-28 2008-03-28 Compositions comprenant des inhibiteurs d’arnox pour l’inhibition d’espèces d’oxygène réactif

Publications (1)

Publication Number Publication Date
CA2719833A1 true CA2719833A1 (fr) 2009-10-01

Family

ID=40056186

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719833A Abandoned CA2719833A1 (fr) 2008-03-28 2008-03-28 Compositions comprenant des inhibiteurs d'arnox pour l'inhibition d'especes d'oxygene reactif

Country Status (11)

Country Link
EP (1) EP2280714A1 (fr)
JP (1) JP2011515466A (fr)
KR (1) KR20110000745A (fr)
CN (1) CN102014930A (fr)
AU (1) AU2008353441A1 (fr)
CA (1) CA2719833A1 (fr)
EA (1) EA201001558A1 (fr)
IL (1) IL208324A0 (fr)
MX (1) MX2010010668A (fr)
WO (1) WO2009120214A1 (fr)
ZA (1) ZA201007247B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3181121B1 (fr) * 2010-12-03 2020-10-28 EPI Health, LLC Compositions de crème pharmaceutique comprenant de l'oxymetazoline pour traiter la rosacée
WO2012091832A2 (fr) * 2010-12-30 2012-07-05 Avon Products, Inc. Modulation de la dynéine dans la peau
CN102440927B (zh) * 2011-02-10 2012-11-21 漳州市格莱雅化妆品有限公司 一种水仙花美白爽肤水化妆品
CN102641223A (zh) * 2011-02-18 2012-08-22 株式会社爱茉莉太平洋 用于改善肤色或增加皮肤弹性的化妆品组合物
CN102526160B (zh) * 2012-01-31 2015-08-12 王玉石 外用于人体皮肤的组合物及其用途
EP2752196A1 (fr) * 2013-01-03 2014-07-09 Université Bordeaux Segalen Peptides inhibiteurs nox-1 sélectifs et leurs utilisations
US9125843B2 (en) * 2013-10-03 2015-09-08 Elc Management Llc Methods and compositions for improving the appearance of skin
JP6698358B2 (ja) * 2015-03-12 2020-05-27 Ｓｈｉｏｄａライフサイエンス株式会社 汗分泌促進剤及び該汗分泌促進剤を含有するドライスキンの予防薬又は治療薬
KR102309958B1 (ko) * 2015-03-24 2021-10-07 주식회사 엘지생활건강 구근추출물을 포함하는 피부 개선용 조성물
US9750682B2 (en) 2015-07-30 2017-09-05 Elc Management, Llc Methods and compositions for improving the appearance of skin
CN105581364B (zh) * 2016-03-07 2017-07-07 云南瑞升烟草技术（集团）有限公司 一种用于卷烟烟丝中的虾青素微胶囊的制备方法及应用
JP6912771B2 (ja) * 2017-04-11 2021-08-04 学校法人立命館 脂漏性角化症の予防又は改善剤
US10251832B2 (en) 2017-05-26 2019-04-09 Mary Kay Inc. Cosmetic compositions and methods
CN107927779A (zh) * 2017-11-27 2018-04-20 爱可道生物科技有限公司 一种美容养颜口服液及其制备方法
US20230073286A1 (en) * 2019-11-06 2023-03-09 Korea Research Institute Of Bioscience And Biotechnology Cosmetic composition for preventing skin aging and reducing skin wrinkles, comprising viburnum stellato-tomentosum extract
CN115721772B (zh) * 2022-12-15 2024-05-10 湖南中腾湘岳生物科技有限公司 一种可吸收止血材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559328A (en) * 1984-06-21 1985-12-17 Warner-Lambert Company Non-steroidal anti-inflammatory compounds to treat inflammation
LU87408A1 (fr) * 1988-12-16 1990-07-10 Oreal Utilisation de derives salicyles pour le traitement du vieillissement de la peau
ATE198702T1 (de) * 1991-11-25 2001-02-15 Richardson Vicks Inc Verwendungvon salicylsäure zur kontrolle der hautatrophie
EP0614353A1 (fr) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Composition anti-rides et/ou pour la lutte contre l'atrophie de la peau
JPH1180002A (ja) * 1997-09-12 1999-03-23 Noevir Co Ltd 老化防止用皮膚外用剤
FR2782269B1 (fr) * 1998-08-17 2001-08-31 Oreal Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
EP1461010A2 (fr) * 2001-12-28 2004-09-29 Integriderm, Inc. Acide hydroxamique et ses derives comme inhibiteurs de la melanocyte tyrosinase pour eclaircissants topiques de la peau
US20050226947A1 (en) * 2004-02-04 2005-10-13 Dale Kern Agents for sequestering serum aging factors and uses therefore
US20060275229A1 (en) * 2005-05-17 2006-12-07 Sreekumar Pillai Skin care active complex and methods of using same
KR20090004980A (ko) * 2006-04-18 2009-01-12 디에스엠 아이피 어셋츠 비.브이. 살리실산 및 아스코브산을 포함하는 화장품 조성물

Also Published As

Publication number Publication date
IL208324A0 (en) 2010-12-30
WO2009120214A1 (fr) 2009-10-01
MX2010010668A (es) 2011-04-26
KR20110000745A (ko) 2011-01-05
ZA201007247B (en) 2011-12-28
EA201001558A1 (ru) 2011-06-30
AU2008353441A2 (en) 2010-11-25
AU2008353441A1 (en) 2009-10-01
CN102014930A (zh) 2011-04-13
EP2280714A1 (fr) 2011-02-09
JP2011515466A (ja) 2011-05-19

Similar Documents

Publication Publication Date Title
CA2719833A1 (fr) Compositions comprenant des inhibiteurs d'arnox pour l'inhibition d'especes d'oxygene reactif
JP6215364B2 (ja) ＭＣ−１Ｒ、ＭＣ−２Ｒ、およびμオピオイド受容体調節
ES2702607T3 (es) Composición cosmética y método de retardo del crecimiento del vello
Hwang et al. Antiaging effects of the mixture of Panax ginseng and Crataegus pinnatifida in human dermal fibroblasts and healthy human skin
US20080175935A1 (en) Method to Treat Skin Conditions with Narcissus Tazetta Bulb Extract
TWI381847B (zh) 化粧組成物及方法
JP6176893B2 (ja) オレアノイルペプチド組成物および皮膚の加齢を治療する方法
US20090246153A1 (en) Cosmetic compositions for the inhibition of reactive oxygen species
US20110085996A1 (en) External preparation composition for skin comprising ginseng flower or ginseng seed extracts
US20110262553A1 (en) Compositions Suitable For Treating Cutaneous Signs Of Aging
TW457094B (en) Topical composition for enhancing lipid barrier synthesis
US20060257509A1 (en) Cosmetic composition and methods
JP2011519353A (ja) 線維芽細胞の増殖および／または活性を刺激する活性成分
KR20230166109A (ko) 식물 유래 엑소좀-유사 나노소포 또는 엑소좀을 포함하는 조성물 및 그의 사용 방법
WO2009120217A1 (fr) Compositions cosmétiques destinées à l’inhibition d’espèces d’oxygène réactif
US20090246152A1 (en) Naractin compositions for the inhibition of reactive oxygen species
Khiljee et al. Investigation of antiaging and skin rejuvenation potential of phytoconstituents from Pyrus communis loaded topical emulgel.
CA2863591A1 (fr) Utilisation d'extrait de carambole en tant que modulateur de cpt-1 et compositions de celui-ci
Budianti et al. Therapeutic options in dermatoporosis: A case report
BR122024004006A2 (pt) Extrato de torta de sementes de moringa peregrina, composições cosmética e nutricosmética e uso das mesmas
US20230346678A1 (en) Topical compositions containing vitamin c
Yonei et al. Verification of improvement of periorbital wrinkles by using Asakado Skin Care
US20150030548A1 (en) External preparation for skin
WO2023209655A1 (fr) Composition améliorant l'énergie des cellules cutanées
BR112022023517B1 (pt) Método para obter um hidrolisado de proteína a partir de torta de sementes de moringa peregrina, hidrolisados de proteína, seus usos e composição farmacêutica ou dermatológica

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130204

FZDE Discontinued

Effective date: 20150330